Total Payments
$12,856
2024 Payments
$1,758
Companies
33
Transactions
599
Medicare Patients
10,005
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$12,355 (96.1%)
Travel$416.25 (3.2%)
Education$84.86 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,355 | 594 | 96.1% |
| Travel and Lodging | $416.25 | 2 | 3.2% |
| Education | $84.86 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,550 | 97 | $0 (2024) |
| BIOTRONIK INC. | $1,515 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,493 | 93 | $0 (2024) |
| Amgen Inc. | $1,090 | 67 | $0 (2024) |
| Medtronic Vascular, Inc. | $981.37 | 8 | $0 (2018) |
| Merck Sharp & Dohme LLC | $933.34 | 42 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $928.90 | 45 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $875.23 | 51 | $0 (2024) |
| Gilead Sciences, Inc. | $565.05 | 33 | $0 (2019) |
| PFIZER INC. | $442.54 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,758 | 67 | BIOTRONIK INC. ($265.85) |
| 2023 | $1,355 | 58 | Merck Sharp & Dohme LLC ($235.23) |
| 2022 | $1,154 | 60 | Merck Sharp & Dohme LLC ($214.22) |
| 2021 | $1,338 | 78 | Janssen Pharmaceuticals, Inc ($259.46) |
| 2020 | $991.60 | 52 | Janssen Pharmaceuticals, Inc ($270.48) |
| 2019 | $1,539 | 74 | BIOTRONIK INC. ($383.27) |
| 2018 | $2,881 | 109 | Medtronic Vascular, Inc. ($981.37) |
| 2017 | $1,839 | 101 | BIOTRONIK INC. ($288.38) |
All Payment Transactions
599 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiology | ||||||
| 11/29/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $107.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $122.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $30.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $16.22 | General |
| Category: Coronary | ||||||
| 10/07/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $69.99 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $35.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.90 | General |
| Category: Cardiovascular | ||||||
| 09/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: DIABETES | ||||||
| 08/30/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Coronary | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,448 | 4,100 | $696,461 | $398,987 |
| 2022 | 21 | 2,416 | 3,890 | $587,068 | $355,243 |
| 2021 | 21 | 2,805 | 5,543 | $659,134 | $420,594 |
| 2020 | 22 | 2,336 | 5,020 | $502,389 | $328,555 |
Total Patients
10,005
Total Services
18,553
Medicare Billing
$1.5M
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 133 | 133 | $187,400 | $107,247 | 57.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 186 | 186 | $117,825 | $76,871 | 65.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 263 | 266 | $95,710 | $40,998 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 210 | 339 | $44,200 | $27,919 | 63.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 124 | 124 | $35,165 | $22,379 | 63.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 101 | 102 | $30,570 | $18,123 | 59.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 186 | 372 | $22,320 | $17,499 | 78.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 102 | 102 | $27,470 | $16,547 | 60.2% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 68 | 68 | $24,120 | $15,181 | 62.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 126 | 126 | $19,050 | $12,661 | 66.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 103 | $18,055 | $11,889 | 65.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 187 | 187 | $24,950 | $10,618 | 42.6% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 138 | 138 | $18,150 | $8,822 | 48.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 57 | 87 | $6,960 | $4,433 | 63.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 273 | 310 | $9,550 | $3,779 | 39.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 133 | 133 | $8,660 | $3,076 | 35.5% |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 2023 | 31 | 1,294 | $5,176 | $526.22 | 10.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 11 | 12 | $950.00 | $267.12 | 28.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 18 | $180.00 | $151.20 | 84.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 186 | 186 | $118,400 | $82,518 | 69.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 286 | 288 | $103,410 | $46,522 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 240 | 385 | $50,110 | $32,682 | 65.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 155 | 155 | $43,335 | $29,746 | 68.6% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 33 | 33 | $47,400 | $29,099 | 61.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 140 | 143 | $42,790 | $26,947 | 63.0% |
About Dr. Thomas Chen, M.D
Dr. Thomas Chen, M.D is a Cardiovascular Disease healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164415899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Chen, M.D has received a total of $12,856 in payments from pharmaceutical and medical device companies, with $1,758 received in 2024. These payments were reported across 599 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($12,355).
As a Medicare-enrolled provider, Chen has provided services to 10,005 Medicare beneficiaries, totaling 18,553 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Flushing, NY
- Active Since 08/29/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1164415899
Products in Payments
- XARELTO (Drug) $1,434
- ENTRESTO (Drug) $1,029
- ClosureFast (Device) $981.37
- VERQUVO (Drug) $893.86
- ELIQUIS (Drug) $647.77
- JARDIANCE (Drug) $645.01
- Corlanor (Drug) $610.66
- BRILINTA (Drug) $553.91
- LEQVIO (Drug) $502.12
- Repatha (Biological) $456.32
- Vascepa (Drug) $324.05
- PRADAXA (Drug) $310.79
- FARXIGA (Drug) $302.54
- Acticor 7 VR-T DX (Device) $296.92
- OPSUMIT (Drug) $197.67
- NURTEC ODT (Drug) $168.83
- ZONTIVITY (Drug) $147.83
- YOSPRALA (Drug) $95.38
- SAPIEN 3 Ultra RESILIA (Device) $92.47
- AVEIR (Device) $91.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Flushing
Madar Abed, Md, MD
Cardiovascular Disease — Payments: $98,164
Cardiovascular Disease $98,164
Dr. Joseph Ma, Md, MD
Cardiovascular Disease — Payments: $18,815
Cardiovascular Disease $18,815
Dr. Jiong-Ming Hu, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $16,826
Cardiovascular Disease $16,826
Dr. Wai Leung, M.d, M.D
Cardiovascular Disease — Payments: $15,212
Cardiovascular Disease $15,212
Chong Park, Md, MD
Cardiovascular Disease — Payments: $12,111
Cardiovascular Disease $12,111
Dr. Emmanuel Moustakakis, M.d, M.D
Cardiovascular Disease — Payments: $11,161
Cardiovascular Disease $11,161